Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor/ataxia syndrome

Jeanelle Ariza, Craig Steward, Flora Rueckert, Matt Widdison, Robert Coffman, Atiyeh Afjei, Stephen C Noctor, Randi J Hagerman, Paul J Hagerman, Veronica Martinez-Cerdeno

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder associated with premutation alleles of the FMR1 gene that is characterized by progressive action tremor, gait ataxia, and cognitive decline. Recent studies of mitochondrial dysfunction in FXTAS have suggested that iron dysregulation may be one component of disease pathogenesis. We tested the hypothesis that iron dysregulation is part of the pathogenic process in FXTAS. We analyzed postmortem choroid plexus from FXTAS and control subjects, and found that in FXTAS iron accumulated in the stroma, transferrin levels were decreased in the epithelial cells, and transferrin receptor 1 distribution was shifted from the basolateral membrane (control) to a predominantly intracellular location (FXTAS). In addition, ferroportin and ceruloplasmin were markedly decreased within the epithelial cells. These alterations have implications not only for understanding the pathophysiology of FXTAS, but also for the development of new clinical treatments that may incorporate selective iron chelation.

Original languageEnglish (US)
Pages (from-to)88-96
Number of pages9
JournalBrain Research
Volume1598
DOIs
StatePublished - Feb 19 2015

Fingerprint

Choroid Plexus
Iron
Epithelial Cells
Gait Ataxia
Ceruloplasmin
Transferrin Receptors
Tremor
Transferrin
Fragile X Tremor Ataxia Syndrome
Neurodegenerative Diseases
Alleles
Membranes
Genes

Keywords

  • Autism
  • CGG repeat
  • Choroid plexus
  • FMR1
  • Fragile X
  • FXTAS
  • Iron
  • Neurodegeneration
  • Premutation

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor/ataxia syndrome. / Ariza, Jeanelle; Steward, Craig; Rueckert, Flora; Widdison, Matt; Coffman, Robert; Afjei, Atiyeh; Noctor, Stephen C; Hagerman, Randi J; Hagerman, Paul J; Martinez-Cerdeno, Veronica.

In: Brain Research, Vol. 1598, 19.02.2015, p. 88-96.

Research output: Contribution to journalArticle

Ariza, Jeanelle ; Steward, Craig ; Rueckert, Flora ; Widdison, Matt ; Coffman, Robert ; Afjei, Atiyeh ; Noctor, Stephen C ; Hagerman, Randi J ; Hagerman, Paul J ; Martinez-Cerdeno, Veronica. / Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor/ataxia syndrome. In: Brain Research. 2015 ; Vol. 1598. pp. 88-96.
@article{38f680cbd94a4a72a81679cfc08c3618,
title = "Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor/ataxia syndrome",
abstract = "Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder associated with premutation alleles of the FMR1 gene that is characterized by progressive action tremor, gait ataxia, and cognitive decline. Recent studies of mitochondrial dysfunction in FXTAS have suggested that iron dysregulation may be one component of disease pathogenesis. We tested the hypothesis that iron dysregulation is part of the pathogenic process in FXTAS. We analyzed postmortem choroid plexus from FXTAS and control subjects, and found that in FXTAS iron accumulated in the stroma, transferrin levels were decreased in the epithelial cells, and transferrin receptor 1 distribution was shifted from the basolateral membrane (control) to a predominantly intracellular location (FXTAS). In addition, ferroportin and ceruloplasmin were markedly decreased within the epithelial cells. These alterations have implications not only for understanding the pathophysiology of FXTAS, but also for the development of new clinical treatments that may incorporate selective iron chelation.",
keywords = "Autism, CGG repeat, Choroid plexus, FMR1, Fragile X, FXTAS, Iron, Neurodegeneration, Premutation",
author = "Jeanelle Ariza and Craig Steward and Flora Rueckert and Matt Widdison and Robert Coffman and Atiyeh Afjei and Noctor, {Stephen C} and Hagerman, {Randi J} and Hagerman, {Paul J} and Veronica Martinez-Cerdeno",
year = "2015",
month = "2",
day = "19",
doi = "10.1016/j.brainres.2014.11.058",
language = "English (US)",
volume = "1598",
pages = "88--96",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor/ataxia syndrome

AU - Ariza, Jeanelle

AU - Steward, Craig

AU - Rueckert, Flora

AU - Widdison, Matt

AU - Coffman, Robert

AU - Afjei, Atiyeh

AU - Noctor, Stephen C

AU - Hagerman, Randi J

AU - Hagerman, Paul J

AU - Martinez-Cerdeno, Veronica

PY - 2015/2/19

Y1 - 2015/2/19

N2 - Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder associated with premutation alleles of the FMR1 gene that is characterized by progressive action tremor, gait ataxia, and cognitive decline. Recent studies of mitochondrial dysfunction in FXTAS have suggested that iron dysregulation may be one component of disease pathogenesis. We tested the hypothesis that iron dysregulation is part of the pathogenic process in FXTAS. We analyzed postmortem choroid plexus from FXTAS and control subjects, and found that in FXTAS iron accumulated in the stroma, transferrin levels were decreased in the epithelial cells, and transferrin receptor 1 distribution was shifted from the basolateral membrane (control) to a predominantly intracellular location (FXTAS). In addition, ferroportin and ceruloplasmin were markedly decreased within the epithelial cells. These alterations have implications not only for understanding the pathophysiology of FXTAS, but also for the development of new clinical treatments that may incorporate selective iron chelation.

AB - Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder associated with premutation alleles of the FMR1 gene that is characterized by progressive action tremor, gait ataxia, and cognitive decline. Recent studies of mitochondrial dysfunction in FXTAS have suggested that iron dysregulation may be one component of disease pathogenesis. We tested the hypothesis that iron dysregulation is part of the pathogenic process in FXTAS. We analyzed postmortem choroid plexus from FXTAS and control subjects, and found that in FXTAS iron accumulated in the stroma, transferrin levels were decreased in the epithelial cells, and transferrin receptor 1 distribution was shifted from the basolateral membrane (control) to a predominantly intracellular location (FXTAS). In addition, ferroportin and ceruloplasmin were markedly decreased within the epithelial cells. These alterations have implications not only for understanding the pathophysiology of FXTAS, but also for the development of new clinical treatments that may incorporate selective iron chelation.

KW - Autism

KW - CGG repeat

KW - Choroid plexus

KW - FMR1

KW - Fragile X

KW - FXTAS

KW - Iron

KW - Neurodegeneration

KW - Premutation

UR - http://www.scopus.com/inward/record.url?scp=84924126806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924126806&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2014.11.058

DO - 10.1016/j.brainres.2014.11.058

M3 - Article

C2 - 25498860

AN - SCOPUS:84924126806

VL - 1598

SP - 88

EP - 96

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -